212 related articles for article (PubMed ID: 10896637)
1. Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.
Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A
Ann Intern Med; 2000 Jul; 133(2):111-22. PubMed ID: 10896637
[TBL] [Abstract][Full Text] [Related]
2. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.
Nass R; Pezzoli SS; Oliveri MC; Patrie JT; Harrell FE; Clasey JL; Heymsfield SB; Bach MA; Vance ML; Thorner MO
Ann Intern Med; 2008 Nov; 149(9):601-11. PubMed ID: 18981485
[TBL] [Abstract][Full Text] [Related]
3. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial.
Baum HB; Biller BM; Finkelstein JS; Cannistraro KB; Oppenhein DS; Schoenfeld DA; Michel TH; Wittink H; Klibanski A
Ann Intern Med; 1996 Dec; 125(11):883-90. PubMed ID: 8967668
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.
Sesmilo G; Fairfield WP; Katznelson L; Pulaski K; Freda PU; Bonert V; Dimaraki E; Stavrou S; Vance ML; Hayden D; Klibanski A
J Clin Endocrinol Metab; 2002 Apr; 87(4):1692-9. PubMed ID: 11932303
[TBL] [Abstract][Full Text] [Related]
5. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study.
Beauregard C; Utz AL; Schaub AE; Nachtigall L; Biller BM; Miller KK; Klibanski A
J Clin Endocrinol Metab; 2008 Jun; 93(6):2063-71. PubMed ID: 18381581
[TBL] [Abstract][Full Text] [Related]
7. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study.
Christ ER; Cummings MH; Lumb PJ; Crook MA; Sönksen PH; Russell-Jones DL
Clin Endocrinol (Oxf); 1999 Aug; 51(2):173-9. PubMed ID: 10468987
[TBL] [Abstract][Full Text] [Related]
9. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials.
Maison P; Griffin S; Nicoue-Beglah M; Haddad N; Balkau B; Chanson P;
J Clin Endocrinol Metab; 2004 May; 89(5):2192-9. PubMed ID: 15126541
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency.
Liang S; Xue J; Li G
Lipids Health Dis; 2018 Apr; 17(1):66. PubMed ID: 29615058
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.
Hoffman AR; Kuntze JE; Baptista J; Baum HB; Baumann GP; Biller BM; Clark RV; Cook D; Inzucchi SE; Kleinberg D; Klibanski A; Phillips LS; Ridgway EC; Robbins RJ; Schlechte J; Sharma M; Thorner MO; Vance ML
J Clin Endocrinol Metab; 2004 May; 89(5):2048-56. PubMed ID: 15126520
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.
Underwood LE; Attie KM; Baptista J;
J Clin Endocrinol Metab; 2003 Nov; 88(11):5273-80. PubMed ID: 14602761
[TBL] [Abstract][Full Text] [Related]
14. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
[TBL] [Abstract][Full Text] [Related]
15. Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.
Binder EF; Williams DB; Schechtman KB; Jeffe DB; Kohrt WM
Ann Intern Med; 2001 May; 134(9 Pt 1):754-60. PubMed ID: 11329233
[TBL] [Abstract][Full Text] [Related]
16. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.
Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A
J Clin Endocrinol Metab; 2001 Apr; 86(4):1518-24. PubMed ID: 11297577
[TBL] [Abstract][Full Text] [Related]
17. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
Filipsson Nyström H; Barbosa EJ; Nilsson AG; Norrman LL; Ragnarsson O; Johannsson G
J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
[TBL] [Abstract][Full Text] [Related]
18. The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone-deficient adults.
Webster JM; Stewart M; al-Maskari M; Osman I; Kendall-Taylor P; Mitcheson J; Laker MF
Atherosclerosis; 1997 Aug; 133(1):115-21. PubMed ID: 9258415
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.
Franco C; Brandberg J; Lönn L; Andersson B; Bengtsson BA; Johannsson G
J Clin Endocrinol Metab; 2005 Mar; 90(3):1466-74. PubMed ID: 15598680
[TBL] [Abstract][Full Text] [Related]
20. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
